Neuroprotection for Parkinson’s disease: a call for clinically driven experimental design.
Erwan Bezard
The Lancet Neurology. 2003-07-01; 2(7): 393
DOI: 10.1016/s1474-4422(03)00432-0
![PubMed](https://www.bordeaux-neurocampus.fr/wp-content/uploads/2019/01/logoPubMed.png)
Read on PubMed
The Lancet Neurology. 2003-07-01; 2(7): 393
DOI: 10.1016/s1474-4422(03)00432-0
![PubMed](https://www.bordeaux-neurocampus.fr/wp-content/uploads/2019/01/logoPubMed.png)
Read on PubMed